| Homo sapiens |
A549 |
Activity |
nan |
None |
10.1021/acs.jmedchem.5b01203 |
| Homo sapiens |
A549 |
IC50 |
15220.0 |
nM |
10.1021/acs.jmedchem.7b01096 |
| Homo sapiens |
A549 |
IC50 |
36460.0 |
nM |
10.1016/j.bmcl.2021.128230 |
| Homo sapiens |
A549 |
IC50 |
200000.0 |
nM |
10.1021/acs.jmedchem.5b01203 |
| Homo sapiens |
A549/CDDP |
Activity |
nan |
None |
10.1021/acs.jmedchem.5b01203 |
| Homo sapiens |
A549/CDDP |
IC50 |
200000.0 |
nM |
10.1021/acs.jmedchem.5b01203 |
| Homo sapiens |
Bel-7402 |
IC50 |
20000.0 |
nM |
10.1016/j.ejmech.2018.01.097 |
| Homo sapiens |
Bile salt export pump |
IC50 |
1000000.0 |
nM |
10.1124/dmd.112.047068 |
| Homo sapiens |
ECV-304 |
Activity |
10.4 |
% |
10.1016/j.ejmech.2011.09.030 |
| Homo sapiens |
ECV-304 |
Activity |
12.71 |
% |
10.1016/j.ejmech.2011.09.030 |
| Homo sapiens |
ECV-304 |
Activity |
22.08 |
% |
10.1016/j.ejmech.2011.09.030 |
| Homo sapiens |
ECV-304 |
Activity |
42.75 |
% |
10.1016/j.ejmech.2011.09.030 |
| Homo sapiens |
ECV-304 |
EC50 |
154350.0 |
nM |
10.1016/j.bmc.2009.03.012 |
| Homo sapiens |
ECV-304 |
EC50 |
452000.0 |
nM |
10.1016/j.bmc.2007.03.033 |
| Homo sapiens |
ECV-304 |
EC50 |
549000.0 |
nM |
10.1016/j.ejmech.2018.01.097 |
| Homo sapiens |
ECV-304 |
EC50 |
600000.0 |
nM |
10.1016/j.ejmech.2011.09.030 |
| Homo sapiens |
HCT-116 |
IC50 |
8170.0 |
nM |
10.1021/acs.jmedchem.7b01096 |
| Homo sapiens |
HeLa |
IC50 |
20000.0 |
nM |
10.1016/j.ejmech.2018.01.097 |
| Homo sapiens |
HepG2 |
IC50 |
20000.0 |
nM |
10.1016/j.ejmech.2018.01.097 |
| Homo sapiens |
HepG2 |
IC50 |
38250.0 |
nM |
10.1016/j.bmcl.2021.128230 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-3.53 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
5.19 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Homo sapiens |
T1/2 |
2.89 |
hr |
10.1016/j.bmc.2009.03.012 |
| Homo sapiens |
HT-29 |
IC50 |
20000.0 |
nM |
10.1016/j.ejmech.2018.01.097 |
| Homo sapiens |
HUVEC |
EC50 |
600000.0 |
nM |
10.1016/j.ejmech.2018.01.097 |
| Homo sapiens |
HUVEC |
EC50 |
788000.0 |
nM |
10.1016/j.ejmech.2018.01.097 |
| Homo sapiens |
HUVEC |
Pmax |
20.66 |
% |
10.1016/s0960-894x(03)00359-7 |
| Homo sapiens |
K562 |
IC50 |
5090.0 |
nM |
10.1021/acs.jmedchem.7b01096 |
| Homo sapiens |
MCF7 |
IC50 |
20000.0 |
nM |
10.1016/j.ejmech.2018.01.097 |
| Homo sapiens |
MCF7 |
IC50 |
29850.0 |
nM |
10.1016/j.bmcl.2021.128230 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
20440.0 |
nM |
10.1016/j.bmcl.2021.128230 |
| Homo sapiens |
SH-SY5Y |
EC50 |
17590.0 |
nM |
10.1016/j.ejmech.2019.111695 |
| Homo sapiens |
Thioredoxin reductase |
IC50 |
200000.0 |
nM |
10.1021/acs.jmedchem.5b01203 |
| Homo sapiens |
U-87 MG |
IC50 |
16150.0 |
nM |
10.1021/acs.jmedchem.7b01096 |
| Oryctolagus cuniculus |
Plasma |
Activity |
3.28 |
g/L |
10.1016/j.bmcl.2019.08.012 |
| Oryctolagus cuniculus |
Plasma |
Activity |
7.86 |
% |
10.1016/j.bmc.2007.03.033 |
| Oryctolagus cuniculus |
Plasma |
APTT |
39.24 |
s |
10.1016/j.bmcl.2019.08.012 |
| Oryctolagus cuniculus |
Plasma |
PT |
6.13 |
s |
10.1016/j.bmcl.2019.08.012 |
| Oryctolagus cuniculus |
Plasma |
TT |
25.36 |
s |
10.1016/j.bmcl.2019.08.012 |
| Rattus norvegicus |
PC-12 |
Activity |
nan |
None |
10.1016/j.bmcl.2019.08.012 |
| Rattus norvegicus |
PC-12 |
EC50 |
60000.0 |
nM |
10.1016/j.ejmech.2018.01.097 |
| Rattus norvegicus |
PC-12 |
EC50 |
64460.0 |
nM |
10.1016/j.ejmech.2018.01.097 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
8.0 |
% |
10.1016/j.bmcl.2016.01.015 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
15.0 |
% |
10.1016/j.bmcl.2016.01.015 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
16.2 |
% |
10.1016/j.bmcl.2016.01.015 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
46.3 |
% |
10.1016/j.bmc.2008.08.075 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1016/j.bmcl.2016.01.015 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1016/j.bmcl.2019.08.012 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
50.0 |
% |
10.1016/j.bmc.2008.08.075 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
71.2 |
% |
10.1016/j.bmc.2008.08.075 |
| Rattus norvegicus |
Thoracic aorta |
EC50 |
2330000.0 |
nM |
10.1016/j.ejmech.2018.01.097 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
10.86 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
32.16 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.08 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.06 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
35.14 |
% |
10.21203/rs.3.rs-23951/v1 |
| None |
Molecular identity unknown |
Activity |
nan |
None |
10.1016/j.bmc.2008.08.075 |
| None |
Neuron |
Activity |
58.4 |
% |
10.1016/j.bmc.2012.04.016 |
| None |
NON-PROTEIN TARGET |
Activity |
7.86 |
% |
10.1016/j.bmc.2009.03.012 |
| None |
NON-PROTEIN TARGET |
Activity |
10.4 |
% |
10.1039/C3MD20352B |
| None |
NON-PROTEIN TARGET |
Activity |
11.4 |
% |
10.1039/C4MD00022F |
| None |
NON-PROTEIN TARGET |
Activity |
12.7 |
% |
10.1039/C3MD20352B |
| None |
NON-PROTEIN TARGET |
Activity |
13.6 |
% |
10.1039/C4MD00022F |
| None |
NON-PROTEIN TARGET |
Activity |
22.1 |
% |
10.1039/C3MD20352B |
| None |
NON-PROTEIN TARGET |
Activity |
22.1 |
% |
10.1039/C4MD00022F |
| None |
NON-PROTEIN TARGET |
Activity |
40.9 |
% |
10.1039/C4MD00022F |
| None |
NON-PROTEIN TARGET |
Activity |
42.8 |
% |
10.1039/C3MD20352B |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1016/j.bmc.2012.04.016 |
| None |
NON-PROTEIN TARGET |
EC50 |
83400.0 |
nM |
10.1039/C4MD00022F |
| None |
NON-PROTEIN TARGET |
EC50 |
600000.0 |
nM |
10.1039/C3MD20352B |
| None |
NON-PROTEIN TARGET |
IC50 |
265300.0 |
nM |
10.1039/C4MD00022F |
| None |
NON-PROTEIN TARGET |
Inhibition |
3.4 |
% |
10.1039/C4MD00022F |
| None |
NON-PROTEIN TARGET |
Inhibition |
6.6 |
% |
10.1016/j.bmc.2008.08.075 |
| None |
NON-PROTEIN TARGET |
Inhibition |
8.6 |
% |
10.1039/C4MD00022F |
| None |
NON-PROTEIN TARGET |
Inhibition |
9.0 |
% |
10.1016/j.bmc.2008.08.075 |
| None |
NON-PROTEIN TARGET |
Inhibition |
15.3 |
% |
10.1039/C4MD00022F |
| None |
NON-PROTEIN TARGET |
Inhibition |
19.6 |
% |
10.1039/C4MD00022F |
| None |
No relevant target |
LogP |
1.26 |
None |
10.1016/j.bmcl.2019.08.012 |
| None |
No relevant target |
solubility |
4.5 |
10'3ug/ml |
10.1016/j.bmcl.2019.08.012 |
| None |
Platelet |
Activity |
42.9 |
% |
10.1016/j.bmc.2012.04.016 |
| None |
Platelet |
Inhibition |
36.2 |
% |
10.1016/j.bmc.2008.08.075 |
| None |
Radical scavenging activity |
Activity |
nan |
None |
10.1016/j.bmc.2012.04.016 |
| None |
Unchecked |
EC50 |
15180.0 |
nM |
10.1016/j.ejmech.2019.111695 |
| None |
Unchecked |
Log 1/C |
nan |
None |
10.1021/jm001129m |